Virtu Financial’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-6,038
| Closed | -$44K | – | 2497 |
|
|
2022
Q3 | $44K | Buy |
6,038
+4,944
| +452% | +$36K | ﹤0.01% | 1234 |
|
|
2022
Q2 | $14K | Buy |
+1,094
| New | +$14K | ﹤0.01% | 1394 |
|
|
2020
Q4 | – | Sell |
-67
| Closed | -$4K | – | 1917 |
|
|
2020
Q3 | $4K | Buy |
+67
| New | +$4K | ﹤0.01% | 972 |
|
|
2019
Q4 | $22K | Sell |
178
-17
| -9% | -$2.1K | ﹤0.01% | 1316 |
|
|
2019
Q3 | $23K | Buy |
195
+22
| +13% | +$2.6K | ﹤0.01% | 1279 |
|
|
2019
Q2 | $52K | Buy |
+173
| New | +$52K | ﹤0.01% | 1210 |
|
|
2019
Q1 | – | Sell |
-179
| Closed | -$82K | – | 1993 |
|
|
2018
Q4 | $82K | Sell |
179
-58
| -24% | -$26.6K | ﹤0.01% | 1174 |
|
|
2018
Q3 | $215K | Buy |
+237
| New | +$215K | 0.01% | 1040 |
|
|
2018
Q2 | – | Sell |
-435
| Closed | -$284K | – | 2645 |
|
|
2018
Q1 | $284K | Buy |
+435
| New | +$284K | 0.02% | 1092 |
|
|
2017
Q4 | – | Sell |
-351
| Closed | -$107K | – | 3187 |
|
|
2017
Q3 | $107K | Buy |
+351
| New | +$107K | 0.01% | 2059 |
|